全国性研究:髋部骨折患者输血情况——苏格兰髋部骨折审计与苏格兰国家输血服务链接分析
该回顾性队列研究链接苏格兰髋部骨折审计与苏格兰国家输血服务2016年5月至2020年12月数据,纳入23,266例≥50岁髋部骨折患者,评估围手术期输血实践及其与临床结局的关联。结果显示总体输血率28.7%,医院间差异16.6%至37.4%,输血与30天死亡率(OR 1.35)、60天死亡率(OR 1.54)升高及术后活动延迟、不返家可能性增高、住院时间延长相关。作者认为输血相关不良结局可能反映围手术期贫血而非因果效应。
要点
- 髋部骨折患者住院期间总体输血率为28.7%,医院间差异为16.6%至37.4%。
- 输血与30天死亡率(OR 1.35)和60天死亡率(OR 1.54)升高相关。
- 输血还与术后活动延迟、不返家可能性增高及住院时间延长相关。
核心结论
- 髋部骨折后输血常见,但全国实践存在差异;输血与不良结局相关,最可能反映围手术期贫血而非因果效应,输血似乎不能逆转该效应,凸显减少围手术期失血的重要性。
研究设计与样本
- 回顾性队列研究,使用苏格兰髋部骨折审计与苏格兰国家输血服务2016年5月至2020年12月的链接数据。
- 纳入所有≥50岁因髋部骨折入住苏格兰医院的患者,共23,266例患者记录,来自18家医院。
主要发现
- 住院期间总体输血率为28.7%(n=6,685),医院间输血率范围为16.6%至37.4%。
- 与输血独立相关的围手术期因素包括年龄较大(90至94岁,OR 3.04(95%CI 2.28至4.04);p<0.001)、髓内固定(OR 7.15(95%CI 6.50至7.86);p<0.001)和滑动髋螺钉构造(OR 2.34(95%CI 2.19至2.50);p<0.001)。
- 住院期间输血与30天死亡率升高相关(OR 1.35(95%CI 1.19至1.53);p<0.001)和60天死亡率升高相关(OR 1.54(95%CI 1.43至1.67);p<0.001)。
- 输血还与术后活动延迟、不返家可能性增高及住院时间延长相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to examine perioperative blood transfusion practice, and associations with clinical outcomes, in a national cohort of hip fracture patients. METHODS: A retrospective cohort study was undertaken using linked data from the Scottish Hip Fracture Audit and the Scottish National Blood Transfusion Service between May 2016 and December 2020. All patients aged ≥ 50 years admitted to a Scottish hospital with a hip fracture were included. Assessment of the factors independently associated with red blood cell transfusion (RBCT) during admission was performed, alongside determination of the association between RBCT and hip fracture outcomes. RESULTS: A total of 23,266 individual patient records from 18 hospitals were included. The overall rate of blood transfusion during admission was 28.7% (n = 6,685). There was inter-hospital variation in transfusion rate, ranging from 16.6% to 37.4%. Independent perioperative factors significantly associated with RBCT included older age (90 to 94 years, odds ratio (OR) 3.04 (95% confidence interval (CI) 2.28 to 4.04); p < 0.001), intramedullary fixation (OR 7.15 (95% CI 6.50 to 7.86); p < 0.001), and sliding hip screw constructs (OR 2.34 (95% CI 2.19 to 2.50); p < 0.001). Blood transfusion during admission was significantly associated with higher rates of 30-day mortality (OR 1.35 (95% CI 1.19 to 1.53); p < 0.001) and 60-day mortality (OR 1.54 (95% CI 1.43 to 1.67); p < 0.001), as well as delays to postoperative mobilization, higher likelihood of not returning to their home, and longer length of stay. CONCLUSION: Blood transfusion after hip fracture was common, although practice varied nationally. RBCT is associated with adverse outcomes, which is most likely a reflection of perioperative anaemia, rather than any causal effect. Use of RBCT does not appear to reverse this effect, highlighting the importance of perioperative blood loss reduction.Cite this article: Bone Joint J 2022;104-B(11):1266-1272.
引用
- Farrow L, Brasnic L, Martin C, et al. A nationwide study of blood transfusion in hip fracture patients : linked analysis from the Scottish Hip Fracture Audit and the Scottish National Blood Transfusion Service. Bone Joint J. 2022. PMID: 36317353. doi:10.1302/0301-620X.104B11.BJJ-2022-0450.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。